Developer docs
API playgroundTry for free, no card

Search company profiles

HealthQuest Capital

Full company profile

uuid00003gd

Namestring
HealthQuest Capital
Legal namestring
HealthQuest Capital Management, L.P.
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRedwood City, United States
HQ citystring
Redwood City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
growth equity investing, healthcare private equity, venture capital funds, healthcare growth capital, private investment management
Industry1 code
1Healthcare & Life Sciences Growth Equity
CodeFSANACABPrimaryYes
NAICS code1 code
  • Other Financial Vehicles525990
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Growth Equity / Private Equity
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

HealthQuest Capital generates revenue through management fees charged on assets under management as a percentage of committed capital, typical for private equity and growth equity funds.

healthquestcapital.com
2Carried Interest
TypeSubscription Recurring
Description

The firm earns carried interest (performance fees) from successful portfolio exits, representing a percentage of profits above the preferred return threshold for LPs.

healthquestcapital.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

HealthQuest Capital is a healthcare-focused growth equity and private investment firm that provides growth capital to commercial-stage healthcare companies across services, healthcare IT, medical devices, diagnostics, and pharma services. The firm operates two primary investment strategies—Growth Equity and Tactical Opportunities—deploying equity and equity-linked securities in structures tailored to each portfolio company's needs, while generating returns for institutional limited partners. Beyond capital, the firm offers strategic guidance, operational expertise, and network connectivity through its Industry Advisory Board.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 23 successful exits through IPO and M&A transactions
+2 more records
Product overview1 text field

HealthQuest Capital is a healthcare-focused growth equity and investment firm that provides capital to transformative healthcare companies. The firm operates two primary investment strategies: Growth Equity and Tactical Opportunities, deploying various investment structures tailored to partner companies. They invest across healthcare services, healthcare IT, medical devices, diagnostics, and pharma services sectors, focusing on commercial-stage companies ready to scale. The firm's portfolio includes 52 portfolio companies across these healthcare subsectors.

Product and service2 records
1Growth Equity Strategy
CategoryInvestment Strategy / Growth Equity Fund
Description

Growth equity investment strategy providing equity and equity-linked capital to commercial-stage healthcare companies ready to scale across services, healthcare IT, medical devices, diagnostics, and pharma services. The strategy supports portfolio companies with operating expertise and network connectivity. Targets commercial-stage healthcare companies and institutional LPs that commit capital to the underlying fund.

2Tactical Opportunities Strategy
CategoryInvestment Strategy / Tactical Opportunities Fund
Description

Tactical opportunities investment strategy that deploys flexible capital structures (including equity and equity-linked securities) tailored to the unique needs of commercial-stage healthcare companies, complementing the firm's Growth Equity strategy. Targets commercial-stage healthcare companies and institutional LPs that commit capital to the underlying fund.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Garheng Kong - Board Roles
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Garheng Kong serves as Lead Independent Director of LabCorp (LH), board member of Smith & Nephew PLC (SNN), Xeris Biopharma (XERS), IKS Health (NSE: IKS), Duke University Health System, Duke University Board of Trustees, Dell Children's Foundation, UT Medicine, UT President's Commercial Advisory Board, and Austin Healthcare Council, providing extensive healthcare industry connections.

healthquestcapital.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

GrowthCap Advisory provides recognition and visibility for HealthQuest Capital through awards including Top Healthcare Investors and Top Private Equity Firm rankings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2012-01-01
Description

HealthQuest Capital maintains an extensive Industry Advisory Board composed of former executives from major healthcare organizations including Kaiser Permanente, LabCorp, Optum Health, Johnson & Johnson, Cardinal Health, Becton Dickinson, Medtronic, Robert Wood Johnson Foundation, and others. This board provides strategic guidance, deal sourcing, and portfolio company support.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused growth equity firm investing in commercial-stage life sciences and healthcare companies. Highly comparable to HealthQuest in stage, sub-sector focus, and fund size.

TypeDirect peer
Description

Dedicated healthcare growth equity firm with both growth and buyout strategies. HealthQuest Partner Sam Brasch was previously an investment professional at Frazier, indicating direct comparability in stage, focus, and approach.

TypeDirect peer
Description

Healthcare-focused growth equity and venture firm with a long track record. HealthQuest Vice President Bill Gerard was previously a Senior Associate at SV Health, and the firms share stage and sub-sector overlap.

TypeDirect peer
Description

Healthcare and life sciences-dedicated platform investing across stages from venture to growth. HealthQuest Associate Hardi Patel was previously an investor at Bain Capital Life Sciences, reflecting overlapping investment mandates.

TypeDirect peer
Description

Large, multi-stage venture and growth equity firm with a significant healthcare practice. HealthQuest Principal Emily Zhen was previously on NEA's healthcare team where she invested over $500M, indicating strong comparability in growth-stage healthcare investing.

TypeDirect peer
Description

Strategic healthcare venture and growth fund affiliated with Kaiser Permanente. HealthQuest Partner Sam Brasch was previously Senior Managing Director of KP Ventures, evidencing direct comparability in commercial-stage healthcare investing.

TypeBroad incumbent
Description

Large-scale life sciences investment platform within Blackstone. HealthQuest Senior Advisor Emmett Cunningham was previously Senior Managing Director at Blackstone Life Sciences, indicating direct overlap in healthcare investing at larger scale.

TypeBroad incumbent
Description

Healthcare-specialist private equity firm with a long history across services, devices, and healthcare IT. Comparable in sub-sector breadth though typically operating at a meaningfully larger AUM than HealthQuest.

TypeDirect peer
Description

Healthcare-dedicated middle-market private equity firm focused on healthcare services and products. Comparable to HealthQuest in healthcare-only mandate, mid-sized AUM, and commercial-stage orientation.

TypeEmerging player
Description

Healthcare-focused investment firm that backs commercial-stage and growth-stage healthcare companies. Comparable sub-sector focus and stage orientation, though with a more limited public track record.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment61 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HealthQuest Capital

Healthcare Growth Equity / Private Equityhealthquestcapital.com

HealthQuest Capital firmographics

Firmographics
Name
HealthQuest Capital
Legal name
HealthQuest Capital Management, L.P.
Website
http://healthquestcapital.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

HealthQuest Capital industry classification

Industry
Product category
Healthcare Growth Equity / Private Equity
NAICS
Other Financial Vehicles (525990)
SIC
Investment Advice (6282)
akta.pro primary industry
Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

  • Growth equity investing
  • Healthcare private equity
  • Venture capital funds
  • Healthcare growth capital
  • Private investment management

Where HealthQuest Capital is headquartered

Location

Headquarters

HQ city
Redwood City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HealthQuest Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Management Fees: HealthQuest Capital generates revenue through management fees charged on assets under management as a percentage of committed capital, typical for private equity and growth equity funds.
  2. Carried Interest: The firm earns carried interest (performance fees) from successful portfolio exits, representing a percentage of profits above the preferred return threshold for LPs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

HealthQuest Capital product offering

Product offering

Core offering

HealthQuest Capital is a healthcare-focused growth equity and private investment firm that provides growth capital to commercial-stage healthcare companies across services, healthcare IT, medical devices, diagnostics, and pharma services. The firm operates two primary investment strategies—Growth Equity and Tactical Opportunities—deploying equity and equity-linked securities in structures tailored to each portfolio company's needs, while generating returns for institutional limited partners. Beyond capital, the firm offers strategic guidance, operational expertise, and network connectivity through its Industry Advisory Board.

Product overview

HealthQuest Capital is a healthcare-focused growth equity and investment firm that provides capital to transformative healthcare companies. The firm operates two primary investment strategies: Growth Equity and Tactical Opportunities, deploying various investment structures tailored to partner companies. They invest across healthcare services, healthcare IT, medical devices, diagnostics, and pharma services sectors, focusing on commercial-stage companies ready to scale. The firm's portfolio includes 52 portfolio companies across these healthcare subsectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Growth Equity Strategy Growth equity investment strategy providing equity and equity-linked capital to commercial-stage healthcare companies ready to scale across services, healthcare IT, medical devices, diagnostics, and pharma services. The strategy supports portfolio companies with operating expertise and network connectivity. Targets commercial-stage healthcare companies and institutional LPs that commit capital to the underlying fund.
  • Tactical Opportunities Strategy Tactical opportunities investment strategy that deploys flexible capital structures (including equity and equity-linked securities) tailored to the unique needs of commercial-stage healthcare companies, complementing the firm's Growth Equity strategy. Targets commercial-stage healthcare companies and institutional LPs that commit capital to the underlying fund.

Quantifiable outcome

  • 23 successful exits through IPO and M&A transactions
  • +2 more outcomes

Companies that use HealthQuest Capital

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

HealthQuest Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

HealthQuest Capital partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Garheng Kong - Board RolescoreStrategic or Co-development Partner · 1 January 2025Garheng Kong serves as Lead Independent Director of LabCorp (LH), board member of Smith & Nephew PLC (SNN), Xeris Biopharma (XERS), IKS Health (NSE: IKS), Duke University Health System, Duke University Board of Trustees, Dell Children's Foundation, UT Medicine, UT President's Commercial Advisory Board, and Austin Healthcare Council, providing extensive healthcare industry connections.
  • GrowthCap AdvisoryminorStrategic or Co-development Partner · 1 January 2025GrowthCap Advisory provides recognition and visibility for HealthQuest Capital through awards including Top Healthcare Investors and Top Private Equity Firm rankings.
  • Industry Advisory BoardcoreStrategic or Co-development Partner · 1 January 2012HealthQuest Capital maintains an extensive Industry Advisory Board composed of former executives from major healthcare organizations including Kaiser Permanente, LabCorp, Optum Health, Johnson & Johnson, Cardinal Health, Becton Dickinson, Medtronic, Robert Wood Johnson Foundation, and others. This board provides strategic guidance, deal sourcing, and portfolio company support.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

HealthQuest Capital competitors and assessment

Company assessment

Direct peers

  • New Leaf Venture Partners: Healthcare-focused growth equity firm investing in commercial-stage life sciences and healthcare companies. Highly comparable to HealthQuest in stage, sub-sector focus, and fund size.
  • Frazier Healthcare Partners: Dedicated healthcare growth equity firm with both growth and buyout strategies. HealthQuest Partner Sam Brasch was previously an investment professional at Frazier, indicating direct comparability in stage, focus, and approach.
  • SV Health Investors: Healthcare-focused growth equity and venture firm with a long track record. HealthQuest Vice President Bill Gerard was previously a Senior Associate at SV Health, and the firms share stage and sub-sector overlap.
  • Bain Capital Life Sciences: Healthcare and life sciences-dedicated platform investing across stages from venture to growth. HealthQuest Associate Hardi Patel was previously an investor at Bain Capital Life Sciences, reflecting overlapping investment mandates.
  • New Enterprise Associates (NEA): Large, multi-stage venture and growth equity firm with a significant healthcare practice. HealthQuest Principal Emily Zhen was previously on NEA's healthcare team where she invested over $500M, indicating strong comparability in growth-stage healthcare investing.
  • Kaiser Permanente Ventures: Strategic healthcare venture and growth fund affiliated with Kaiser Permanente. HealthQuest Partner Sam Brasch was previously Senior Managing Director of KP Ventures, evidencing direct comparability in commercial-stage healthcare investing.
  • Linden Capital Partners: Healthcare-dedicated middle-market private equity firm focused on healthcare services and products. Comparable to HealthQuest in healthcare-only mandate, mid-sized AUM, and commercial-stage orientation.

Broad incumbents

  • Blackstone Life Sciences: Large-scale life sciences investment platform within Blackstone. HealthQuest Senior Advisor Emmett Cunningham was previously Senior Managing Director at Blackstone Life Sciences, indicating direct overlap in healthcare investing at larger scale.
  • Welsh, Carson, Anderson & Stowe: Healthcare-specialist private equity firm with a long history across services, devices, and healthcare IT. Comparable in sub-sector breadth though typically operating at a meaningfully larger AUM than HealthQuest.

Emerging players

  • Gurnet Point Capital: Healthcare-focused investment firm that backs commercial-stage and growth-stage healthcare companies. Comparable sub-sector focus and stage orientation, though with a more limited public track record.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

HealthQuest Capital social profiles

Digital presence

HealthQuest Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HealthQuest Capital leadership team

Management profile

Number of profiles

Profiles16 records

HealthQuest Capital funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HealthQuest Capital M&A and investment

M&A and investment

M&A

Investments61 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthQuest Capital

What does HealthQuest Capital do?

HealthQuest Capital is a healthcare-focused growth equity and private investment firm that provides growth capital to commercial-stage healthcare companies across services, healthcare IT, medical devices, diagnostics, and pharma services. The firm operates two primary investment strategies—Growth Equity and Tactical Opportunities—deploying equity and equity-linked securities in structures tailored to each portfolio company's needs, while generating returns for institutional limited partners. Beyond capital, the firm offers strategic guidance, operational expertise, and network connectivity through its Industry Advisory Board.

Is HealthQuest Capital a public or private company?

HealthQuest Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was HealthQuest Capital founded?

HealthQuest Capital was founded in 2013. It employs 11 to 50 people.

Where is HealthQuest Capital based?

HealthQuest Capital is headquartered in Redwood City, United States, in the North America region.

How does HealthQuest Capital make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.

Who are HealthQuest Capital's main competitors?

Direct peers on record are New Leaf Venture Partners, Frazier Healthcare Partners, SV Health Investors, Bain Capital Life Sciences, New Enterprise Associates (NEA), Kaiser Permanente Ventures and Linden Capital Partners. Broad incumbents are Blackstone Life Sciences and Welsh, Carson, Anderson & Stowe. Gurnet Point Capital is listed as an emerging player.

Does HealthQuest Capital have an API?

No public API is recorded for HealthQuest Capital.

What industry is HealthQuest Capital in?

HealthQuest Capital's product category is Healthcare Growth Equity / Private Equity. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 525990 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology EcosystemThyme Care raised over $125 million in a Series E round led by Morgan Health, with participation from Humana, CVS Health Ventures, and others. The company, serving 10.5 million people and managing $7 billion in oncology spend, is establishing Thyme Companies to build new oncology businesses, with the first expected later this year.FinSMEsThyme Care Closes Over $125M Series E FundingThyme Care, a Nashville oncology company, raised over $125M in Series E financing led by Morgan Health, with participation from Humana, CVS Health Ventures, and others. The company manages over $7B in oncology spend and is profitable. It will use funds to accelerate growth and establish Thyme Companies, a parent entity for new oncology businesses, with the first expected later this year.BioSpaceConnie Health Announces Acquisition of Clearlink Insurance Agency and Series B Funding to Accelerate Growth in MedicareConnie Health completed its acquisition of Clearlink's Medicare business, its 10th acquisition, and announced a $40 million Series B led by HealthQuest Capital. The round brings total funding to $85 million, supporting further acquisitions and agent network growth.CoveragerConnie Health buys Clearlink’s Medicare businessConnie Health completed its acquisition of Clearlink's Medicare business and closed a $40 million Series B round led by HealthQuest Capital. The funding brings total investment to $85 million, and Clearlink is the tenth acquisition. Connie Health is positioning itself as a partner to Accountable Care Organizations and health systems.FinSMEsConnie Health Closes Series B Funding; Acquires Clearlink Insurance AgencyConnie Health raised an undisclosed Series B led by HealthQuest Capital, bringing total funding to $85M. The company will use the funds to expand operations and development, and it acquired Clearlink Insurance Agency, an independent insurance broker.Bhbusiness‘We’ve Dug Ourselves Into This Hole’: What It Takes for Autism Providers to Succeed in a Challenging MarketThe autism therapy industry in the US faces significant headwinds as payers are expected to aggressively cut reimbursement rates, increase audits, and tighten prior authorization processes beginning in 2026. Industry leaders from AnswersNow, JoyBridge Kids, and HealthQuest Capital argue that providers must shift toward outcome-based payment models and adopt technology-driven efficiency to survive the coming financial pressure. The article predicts market consolidation as lower-quality providers are forced to exit, while companies that can demonstrate data-driven quality and reduce administrative burdens may still find opportunity amid the turmoil.YahooOrganOx Completes $142 Million Equity Financing Led by HealthQuest CapitalOrganOx completed a $142 million equity financing led by HealthQuest Capital, with support from existing and new investors. The funds will accelerate growth of its metra platform, used in over 5,000 liver transplants, and support upcoming kidney trials and a first-in-human study with eGenesis.HLTHRoyal Health Secures Strategic Investment from HealthQuest CapitalRoyal Health, a radiology software provider and part of Royal Solutions Group, announced it has received a minority investment from HealthQuest Capital, leading to a significant increase in valuation since 2019. The investment aims to support Royal Health’s strategic growth, technology development, and international expansion, positioning it as a global leader in radiology workflow solutions.BenzingaHealthQuest Capital Invests in Royal Health Inc to Accelerate Innovation in Radiology Operational SolutioHealthQuest Capital led a minority investment in Royal Health Inc, a radiology software provider, with the funding amount undisclosed. The recapitalization nearly eightfolded the company's enterprise valuation since 2019 investors entered. The investment will support scaling operations, enhancing technology, and expanding in U.S. and international markets.CellipontCellipont Bioservices Announces Darren Head As Chief Executive Officer & Minority Growth Equity Investment From HealthQuest Capital - Cell Therapy CDMOCellipont Bioservices appointed Darren Head as its new Chief Executive Officer and Chairman of the Board, while simultaneously securing a minority growth equity investment from HealthQuest Capital. Great Point Partners, Cellipont's majority investor, also participated in this financing round to support the company's expansion strategy.